Nutra Pharma Corp (NPHC) stock
NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $806.69KP/E –Yield –
Nutra Pharma ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Nutra Pharma's ebitda for the twelve months ending Sep 30, 2018 was -$1.80M. For fiscal 2021 it was -$1.98M. The highest annual figure on record is -$921.12K in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -$1.98M | – |
| FY2020 | Dec 31, 2020 | -$921.12K | – |
| FY2017 | Dec 31, 2017 | -$1.38M | – |
| FY2016 | Dec 31, 2016 | -$2.03M | – |
| FY2015 | Dec 31, 2015 | -$5.75M | – |
| FY2014 | Dec 31, 2014 | -$2.19M | – |
| FY2013 | Dec 31, 2013 | -$2.35M | – |
| FY2012 | Dec 31, 2012 | -$2.59M | – |
| FY2011 | Dec 31, 2011 | -$3.93M | – |
| FY2010 | Dec 31, 2010 | -$3.38M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2018 | Sep 30, 2018 | -$853.15K | – |
| Q2 FY2018 | Jun 30, 2018 | -$334.02K | – |
| Q1 FY2018 | Mar 31, 2018 | -$335.53K | – |
| Q4 FY2017 | Dec 31, 2017 | -$273.07K | – |
| Q1 FY2017 | Mar 31, 2017 | -$416.17K | – |
| Q2 FY2016 | Jun 30, 2016 | -$606.66K | – |
| Q1 FY2016 | Mar 31, 2016 | -$352.48K | – |
See a number that looks wrong?